Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Outlook for the Antisense & RNAi Therapeutics Market Heading Into 2029?

There has been a swift expansion of the pontine glioma drugs market size in the past few years. The market is set to flourish from $0.98 billion in 2024 to $1.08 billion in 2025, with a compound annual growth rate (CAGR) of 10.3%. This growth witnessed in the historic period can be credited to the increasing awareness and acceptance, progress in medical imaging technology, and initiatives towards research and clinical trials.

In the coming years, the market size for pontine glioma drugs is set to escalate quickly, with an expected valuation of “$1.6 billion in 2029 at a compound annual growth rate (CAGR) of 10.4%. This surge during the predicted period can be linked to improvements in precision medicine, international cooperation and funding, novel developments in immunotherapy, and target-oriented therapies. Immuno-oncology enhancements, nanotechnology, gene therapy, combination therapies, and the regulatory environment are the major trends during this forecast period.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15899&type=smp

Which Factors Are Pushing The Antisense & RNAi Therapeutics Market Forward?

The surging incidence of maladies such as coronary artery diseases, neurodegenerative disorders, and infectious diseases is predicted to spur the demand for the antisense & RNAi therapeutics market. Treatment strategies that suppress genes, such as RNA interference and antisense oligonucleotides, are employed to treat numerous neurodegenerative disorders by mending defective genes. For example, a report from the American Heart Association, an organization based in the US, stated that in January 2024, the age-adjusted mortality rate from cardiovascular diseases rose to 233.3 per 100,000, a 4.0% increase from the preceding year. Consequently, the rising incidence of multiple neurodegenerative and infectious diseases is anticipated to be a key driver of growth for the antisense & RNAi therapeutics market.

The pontine glioma drugs market covered in this report is segmented –

1) By Type: Diffuse Brain Stem Glioma, Focal Brain Stem Glioma, Recurrent Brain Stem Glioma

2) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy

3) By Application: Cancer Research Institutes, Diagnostic Laboratories, Hospitals

Subsegments:

1) By Diffuse Brain Stem Glioma: Chemotherapy Treatments, Targeted Therapy, Immunotherapy Drugs

2) By Focal Brain Stem Glioma: Surgical Intervention Drugs, Radiation Therapy Drugs, Chemotherapy Agents

3) By Recurrent Brain Stem Glioma: Experimental Drug Therapies, Combination Chemotherapy, Personalized Medicine Approaches

How Are Key Trends Driving Expansion In The Antisense & RNAi Therapeutics Industry?

The pontine glioma drugs market is comprised of major businesses shifting their focus towards the creation of innovative products such as small-molecule chemotherapeutics in order to elevate their market revenues. These small-molecule chemotherapeutics are drugs made up of relatively lower molecular weight compounds that can efficiently infiltrate the blood-brain barrier to access the tumor situated in pontine glioma. For instance, in December 2022, U.S. clinical-stage drug development company, Kintara Therapeutic, was granted an orphan drug designation by the Food and Drug Administration (FDA) for their drug named VAL-083, designed for the treatment of Diffuse Intrinsic Pontine Glioma (DIPG). VAL-083, a small-molecule chemotherapeutic, is a pioneer in its class with a distinctive mechanism of action and has demonstrated clinical success against a range of cancers such as central nervous system, ovarian and other solid tumors. This designation emphasizes the potential of VAL-083 in the field of treating this complex brain tumor, highlighting the commitment to cater to the urgent medical requirements in the DIPG treatment field.

Which Organizations Are Driving Progress In The Antisense & RNAi Therapeutics Industry?

Major companies operating in the pontine glioma drugs market are Pfizer Inc., F. Hoffmann-La Roche AG, Merck & Co. Inc., AbbVie Inc., Sanofi S.A, Bristol-Myers Squibb Company, AstraZeneca, Novartis AG, GlaxoSmithKline PLC, Eli Lilly and Company, Teva Pharmaceutical Industries, Daiichi Sankyo Company Limited, The Menarini Group, Y-mAbs Therapeutics, Agios Pharmaceuticals, Kazia Therapeutic, DNAtrix Inc., Aminex Therapeutics Inc., Accendatech Co Ltd., Arog Pharmaceuticals, Kintara Therapeutics Inc., Medicenna Therapeutics, Alaunos Therapeutics, Biodexa Pharmaceuticals PLC

https://www.thebusinessresearchcompany.com/report/pontine-glioma-drugs-global-market-report

Which Region Is Expected To Experience The Highest Growth In The Antisense & RNAi Therapeutics Industry?

North America was the largest region in the pontine glioma drugs market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pontine glioma drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=15899&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model